You have to be registered and logged in for purchasing articles.
Abstract |
Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease |
Background: Inflammatory bowel disease (IBD) is a multifactorial immunologically mediated disorder characterized by repeated cycles of exacerbations and remissions. Diagnosis and monitoring of ulcerative colitis (UC) and Crohn's disease (CD) as common types of IBD require the usage of unpleasant invasive methods such as colonoscopy and cross-sectional imaging. Development of a non-invasive biomarker panel including different inflammatory parameters for evaluation of various aspects of gut inflammation and disease course is a priority task. In addition to the well-known inflammatory markers serum C-reactive protein (CRP) and fecal calprotectin (FC), adenosine deaminase (ADA) could be a promising candidate-biomarker. ADA has been shown to increase in several inflammatory conditions, but little is known about its significance in IBD. This preliminary research aims to study the serum levels of ADA in IBD patients and to evaluate its ability to adequately reflect the gut inflammatory process.
|